Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom.

Dexcom has invested $75 million into Oura, which values Oura at $5 billion. And the details of the deal could have a ...

DexCom (NASDAQ:DXCM) is investing $75M in Finnish health tech firm ŌURA as part of the latter’s Series D funding round. ŌURA, ...

Oura and glucose monitoring company Dexcom have formed an agreement to share data between apps, but the partnership goes even ...

Rather, new integrations will enable data to move between Dexcom glucose biosensors, Oura Rings and the apps that work with ...

Oura is partnering with medical device maker Dexcom to integrate data from glucose biosensors with the Oura Ring, which ...

A glucose screening test is a standard test during pregnancy to help identify gestational diabetes. The test is done in two steps and checks a pregnant person's response to glucose (sugar). High ...

CGMs are prescribed to diabetics to monitor their blood sugar. They're now available and becoming wildly popular for over-the ...

Dexcom has rounded up its celebrity spokespeople for World Diabetes Day, putting singer Nick Jonas at the center of a ...

The question is more urgent as over-the-counter continuous glucose monitoring devices become more widely available.

BUT IMAGINE GETTING $1,000 BILLS EVERY MONTH. YEAH, THAT’S THE SHOCKING REALITY FOR SOME PEOPLE WHO THINK THEIR ELECTRIC METERS MIGHT BE TO BLAME. THEY SAY TRYING TO GET A METER REPLACED HAS ...

Diabetes describes a group of metabolic diseases characterized by high blood sugar levels. Diabetes can be caused by the pancreas not producing insulin (type 1 diabetes) or by insulin resistance ...